Literature DB >> 16545547

Meningocele and ankyloblepharon following in utero exposure to olanzapine.

M Arora1, S K Praharaj.   

Abstract

Although atypical antipsychotics are widely used during pregnancy, their safety is not well established. This case highlights the possible teratogenic effect of olanzapine, in which the baby was born with meningocele and ankyloblepharon. It is suggested that olanzapine may interfere with embryonic development at different stages of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545547     DOI: 10.1016/j.eurpsy.2006.01.014

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

Review 1.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

Review 2.  Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.

Authors:  Elizabeth Brunner; Deborah M Falk; Meghan Jones; Debashish K Dey; Chetan Chinmaya Shatapathy
Journal:  BMC Pharmacol Toxicol       Date:  2013-08-01       Impact factor: 2.483

3.  Tracheo-Esophageal Fistula (TEF) in a Newborn Following Maternal Antenatal Exposure to Olanzapine.

Authors:  Vikas Maharshi; Indranil Banerjee; Pravesh Nagar; Harmeet Singh Rehan
Journal:  Drug Saf Case Rep       Date:  2017-12

4.  Meningomyelocele on Exposure to Clozapine During Perinatal Period.

Authors:  Prakruthi Narayanaswamy; K S Shaji; T P Sumesh
Journal:  Indian J Psychol Med       Date:  2019 Jul-Aug

Review 5.  Mood stabilizers in pregnancy and lactation.

Authors:  Sandeep Grover; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2015-07       Impact factor: 1.759

6.  Teratogenicity with olanzapine.

Authors:  Sathya Prakash; Rakesh Kumar Chadda
Journal:  Indian J Psychol Med       Date:  2014-01

Review 7.  Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature.

Authors:  Andreea Teodorescu; Petru Ifteni; Marius Alexandru Moga; Victoria Burtea; Nicusor Bigiu
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.